Armatus Bio is an emerging precision therapeutics company at the intersection of genetic science and bioengineering.
Armatus Bio has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Armatus Bio's investors include Solve FSHD, CMTA.
Armatus Bio is headquartered in Columbus, United States.
Armatus Bio is an emerging precision therapeutics company at the intersection of genetic science and bioengineering.
Armatus Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Armatus Bio — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/armatus-bio. Accessed October 30, 2026.
VCBacked. (2025). Armatus Bio — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/armatus-bio
{{cite web |title=Armatus Bio — Funding & Investors |url=https://www.vcbacked.co/company/armatus-bio |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated